The Lancet Rheumatology
订阅
1. [Comment] Targeting sphingosine-1-phosphate receptor modulator in SLE: a promising new therapeutic option Giuseppe Barilaro, Ricard Cervera
2. [Articles] Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra, Clélia Cahuzac, Peter Cornelisse, Mark J Murphy, Daniel S Strasser, Luba Trokan, Ouali Berkani
3. [Viewpoint] Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease Francesco Ciccia, Saviana Gandolfo, Roberto Caporali, Jose U Scher
4. [Articles] Association of historical redlining and present-day racialised economic segregation with health-care utilisation among individuals with rheumatic conditions in Massachusetts and surrounding areas of the USA: a retrospective cohort study Sherry Yang, Leah Santacroce, Jamie E Collins, Candace H Feldman
5. [Clinical Picture] Coronary polyarteritis nodosa Yi-Ning Yen, Hsien-Tzung Liao
6. [Comment] Structural racism is a driver of fragmented care and acute care use among people with rheumatic conditions João Luiz Bastos
7. [Comment] Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade Jill P Buyon, Philip M Carlucci, Bettina F Cuneo, Mala Masson, Peter Izmirly, Nalani Sachan, Justin S Brandt, Shilpi Mehta-Lee, Marc Halushka, Kristen Thomas, Melanie Fox, Colin KL Phoon, Achiau Ludomirsky, Ranjini Srinivasan, Garrett Lam, Benjamin J Wainwright, Nicola Fraser, Robert Clancy
8. [Articles] CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series Janina Auth, Fabian Müller, Simon Völkl, Nadine Bayerl, Jörg H W Distler, Carlo Tur, Maria G Raimondo, Sara Chenguiti Fakhouri, Armin Atzinger, Birte Coppers, Markus Eckstein, Anna-Maria Liphardt, Tobias Bäuerle, Koray Tascilar, Michael Aigner, Sascha Kretschmann, Andreas Wirsching, Jule Taubmann, Melanie Hagen, Andrea-Hermina Györfi, Soraya Kharboutli, Tobias Krickau, Clara Dees, Silvia Spörl, Tobias Rothe, Thomas Harrer, Aline Bozec, Ricardo Grieshaber-Bouyer, Florian Fuchs, Torsten Kuwert, Carola Berking, Raymund E Horch, Michael Uder, Andreas Mackensen, Georg Schett, Christina Bergmann
9. [Comment] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis Jérôme Avouac
10. [Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study Guozhang Lin, Yuchen Wei, Huwen Wang, Christopher Boyer, Katherine Min Jia, Chi Tim Hung, Xiaoting Jiang, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Ka Chun Chong, Eng Kiong Yeoh
11. [Articles] Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study Arthiha Velauthapillai, Catharina C Moor, Jeska K de Vries-Bouwstra, Marlies S Wijsenbeek-Lourens, Cornelia H M van den Ende, Madelon C Vonk
12. [Comment] Are we ready for home spirometry for systemic sclerosis-associated ILD? Jessica Channick, Elizabeth R Volkmann
13. [Comment] Immunosuppression, nirmatrelvir–ritonavir, and post-COVID condition Jeffrey A Sparks, Zachary S Wallace
14. [Viewpoint] Barriers to CAR T-cell therapy in rheumatology Karolina Lungova, Michael Putman
15. [Articles] Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study Mikkel Østergaard, Mikael Boesen, Walter P Maksymowych, Robert G Lambert, Michael R Bubb, Olga Kubassova, Guillermo Valenzuela, Jyotsna Reddy, Stephen Colgan, Yuri Klyachkin, Cynthia Deignan, Zhenwei Zhou, Hamid Amouzadeh, Philip J Mease
16. [Review] Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, Emanuele Bozzalla-Cassione, Chiara Cardamone, Cosimo Cigolini, Francesco Ferro, Tomas Fonseca, George E Fragoulis, Ilaria Galetti, Maria Gerosa, José Hernández-Rodríguez, Marco Lanzillotta, Diana Marinello, Thierry Martin, Fernando Martinez-Valle, Maria Maślińska, Michele Moretti, Marta Mosca, Ulf Müller-Ladner, Cecilia Nalli, Giovanni Orsolini, Cristina Pamfil, Guillermo Perez-Garcia, Roberta Priori, Giacomo Quattrocchio, Andreas Ramming, Francesca Regola, Vasco C Romão, Augusto Silva, Jan A M van Laar, Maria Jose Vicente-Edo, Shlomo Vinker, Tobias Alexander
17. [Clinical Picture] Facial ulcerations in anti-MDA5 dermatomyositis Rajat Ranka, Sukdev Manna, Venkatesh Srinivasa Pai
18. [Review] Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression Yujie Shen, Jinchao Jia, Jialin Teng, Chengde Yang, Qiongyi Hu
19. [Articles] Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study Mark D Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey, Maryam A Adas, Edward Alveyn, Samir Patel, Zijing Yang, Katie Bechman, Elizabeth Price, Sarah Gallagher, Andrew P Cope, Sam Norton, James B Galloway
20. [Clinical Picture] Constitutional symptoms of severe childhood-onset polyarteritis nodosa Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi Sinha, Narendra Kumar Bagri
21. [Viewpoint] The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica Elizabeth Nettleton, Kylie Carlson, Michael Putman
22. [Articles] Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study Alexandra Kachaner, Arthur Mageau, Tiphaine Goulenok, Chrystelle François, Nicole Delory, Marie-Paule Chauveheid, Cedric Laouenan, Serge Doan, Caroline Halimi, Isabelle Klein, Thomas Papo, Karim Sacré, French Susac Study Group
23. [Comment] Susac syndrome: challenges of interpreting treatment data in a rare disease Todd A Hardy
24. [Review] Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis Dylan McGagh, Kaiyang Song, Hang Yuan, Andrew P Creagh, Sally Fenton, Wan-Fai Ng, Jennifer C Goldsack, William G Dixon, Aiden Doherty, Laura C Coates
25. [Clinical Picture] Painful scalp nodules in SAPHO syndrome Clément Triaille, Victor Kokta, Julie Powell, Jean Jacques De Bruycker
26. [Clinical Picture] Pachydermodactyly: mimic of arthritis in a young man Cassandra Michelle Skinner-Taylor, Pablo Gamez-Siller, Brenda Cantu-Garza, Hector Guerra, Héctor Teodoro Rios-Bazaldua, Dionicio Angel Galarza-Delgado, Jesus Alberto Cardenas-de la Garza
27. [Clinical Picture] Takayasu arteritis-associated periostitis in the distal femur mimicking periosteal osteosarcoma Mariko M Kawamura, Robert Nakayama, Sayaka I Yamaguchi, Satoshi Kamio, Toru Hirozane, Tomoaki Mori, Naofumi Asano, Hajime Okita, Morio Matsumoto, Masaya Nakamura
28. [Clinical Picture] Blau syndrome presenting as lipoma arborescens Hanlin Yin, Wanyi Lin, Langxian Zhi, Fuli Yin, Shaoying Yang, Liangjing Lu
29. [Clinical Picture] A fluffy white retinal lesion in a woman with spondyloarthritis treated with tofacitinib Claudia Fabiani, Stefano Gentileschi, Gian Marco Tosi, Luca Cantarini
更新于 34 分钟前

近期历史最近 100 条记录

2024-11-23 [Comment] Targeting sphingosine-1-phosphate receptor modulator in SLE: a promising new therapeutic option Giuseppe Barilaro, Ricard Cervera
2024-11-23 [Articles] Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra, Clélia Cahuzac, Peter Cornelisse, Mark J Murphy, Daniel S Strasser, Luba Trokan, Ouali Berkani
2024-11-21 [Viewpoint] Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease Francesco Ciccia, Saviana Gandolfo, Roberto Caporali, Jose U Scher
2024-11-20 [Articles] Association of historical redlining and present-day racialised economic segregation with health-care utilisation among individuals with rheumatic conditions in Massachusetts and surrounding areas of the USA: a retrospective cohort study Sherry Yang, Leah Santacroce, Jamie E Collins, Candace H Feldman
2024-11-20 [Clinical Picture] Coronary polyarteritis nodosa Yi-Ning Yen, Hsien-Tzung Liao
2024-11-20 [Comment] Structural racism is a driver of fragmented care and acute care use among people with rheumatic conditions João Luiz Bastos
2024-11-16 [Comment] Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade Jill P Buyon, Philip M Carlucci, Bettina F Cuneo, Mala Masson, Peter Izmirly, Nalani Sachan, Justin S Brandt, Shilpi Mehta-Lee, Marc Halushka, Kristen Thomas, Melanie Fox, Colin KL Phoon, Achiau Ludomirsky, Ranjini Srinivasan, Garrett Lam, Benjamin J Wain
2024-11-12 [Comment] Palliative care in patients with rheumatic diseases Bjoern Buehring, Sen Hee Tay, Erika Manu, Raymond Yung
2024-11-12 [Comment] Ageism and rheumatic diseases Devyani Misra, Bjoern Buehring, Raymond Yung, Una E Makris
2024-11-12 [Series] Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities Elena Myasoedova, Sebastian E Sattui, Jiha Lee, John T O'Brien, Una E Makris
2024-11-12 [Series] Frailty and rheumatic diseases: evidence to date and lessons learned Sarah B Lieber, Katherine D Wysham, Sebastian E Sattui, Raymond Yung, Devyani Misra
2024-11-12 [Articles] CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series Janina Auth, Fabian Müller, Simon Völkl, Nadine Bayerl, Jörg H W Distler, Carlo Tur, Maria G Raimondo, Sara Chenguiti Fakhouri, Armin Atzinger, Birte Coppers, Markus Eckstein, Anna-Maria Liphardt, Tobias Bäuerle, Koray Tascilar, Michael Aigner, Sascha Kre
2024-11-12 [Comment] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis Jérôme Avouac
2024-11-12 [Series] Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist Bjoern Buehring, Marloes van Onna, Elena Myasoedova, Jiha Lee, Una E Makris
2024-11-12 [Insights] Una Makris: What matters to older patients, matters most to her Jules Morgan
2024-11-09 [Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study Guozhang Lin, Yuchen Wei, Huwen Wang, Christopher Boyer, Katherine Min Jia, Chi Tim Hung, Xiaoting Jiang, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Ka Chun Chong, E
2024-11-09 [Articles] Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study Arthiha Velauthapillai, Catharina C Moor, Jeska K de Vries-Bouwstra, Marlies S Wijsenbeek-Lourens, Cornelia H M van den Ende, Madelon C Vonk
2024-11-09 [Comment] Are we ready for home spirometry for systemic sclerosis-associated ILD? Jessica Channick, Elizabeth R Volkmann
2024-11-09 [Comment] Immunosuppression, nirmatrelvir–ritonavir, and post-COVID condition Jeffrey A Sparks, Zachary S Wallace
2024-11-06 [Viewpoint] Barriers to CAR T-cell therapy in rheumatology Karolina Lungova, Michael Putman
2024-11-02 [Comment] Digital remote monitoring in rheumatology: using health economics to support wider adoption Sean P Gavan
2024-11-02 [Articles] Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness Kasper Hermans, Casper Webers, Annelies Boonen, Harald E Vonkeman, Astrid van Tubergen
2024-10-31 [Articles] Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study Mikkel Østergaard, Mikael Boesen, Walter P Maksymowych, Robert G Lambert, Michael R Bubb, Olga Kubassova, Guillermo Valenzuela, Jyotsna Reddy, Stephen Colgan, Yuri Klyachkin, Cynthia Deignan, Zhenwei Zhou, Hamid Amouzadeh, Philip J Mease
2024-10-30 [Clinical Picture] Facial ulcerations in anti-MDA5 dermatomyositis Rajat Ranka, Sukdev Manna, Venkatesh Srinivasa Pai
2024-10-30 [Review] Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, Emanuele Bozzalla-Cassione, Chiara Cardamone, Cosimo Cigolini, Francesco Ferro, Tomas Fonseca, George E Fragoulis, Ilaria Galetti, Maria Gerosa, José Hernández-Rodríguez, Marco Lanzillotta, Diana Marin
2024-10-23 [Articles] Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial Hong Zhang, Qianqian Li, Cuiyun Li, Min Wu, Hong Chen, Yang Li, Feng You, Yanshi Zhao, Jing Jin, Xiaoguang Chen, Yanhua Ding
2024-10-23 [Comment] Proximod as a potential therapy for rheumatoid arthritis Chao Liang
2024-10-19 [Review] Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression Yujie Shen, Jinchao Jia, Jialin Teng, Chengde Yang, Qiongyi Hu
2024-10-16 [Articles] Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study Mark D Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey, Maryam A Adas, Edward Alveyn, Samir Patel, Zijing Yang, Katie Bechman, Elizabeth Price, Sarah Gallagher, Andrew P Cope, Sam Norton, James B Galloway
2024-10-16 [Correction] Correction to Lancet Rheumatol 2024; published Online Sept 18, 2024. https://doi.org/10.1016/S2665-9913(24)00220-0
2024-10-12 [Articles] Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial Amanda Malone, Mark M Kowalski, James Helliwell, Sidsel Lynggaard Boll, Helene Rovsing, Kathrine Moriat, Alejandro Castillo Mondragón, Yanqi Li, Claire Prener Miller, Asger Reinstrup Bihlet, Christine Dobek, Vik Peck, Mike Wilmink, Lee S Simon, Philip G C
2024-10-04 [Correspondence] Inclusion of pregnant populations in clinical trials in China: the ethical considerations Xiaoyan Chen, Huifeng Shi, Barbara Wilkinson, Yuanfang Zhu
2024-10-02 [Correspondence] Inclusive study design to better serve the needs of children and young people with rheumatological conditions Ameenat Lola Solebo, Salomey Kellett, UNICORNS Group
2024-09-28 [Corrections] Correction to Lancet Rheumatol 2024; 6: e507–17
2024-09-28 [Clinical Picture] Constitutional symptoms of severe childhood-onset polyarteritis nodosa Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi Sinha, Narendra Kumar Bagri
2024-09-26 [Viewpoint] The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica Elizabeth Nettleton, Kylie Carlson, Michael Putman
2024-09-25 [Comment] Challenges and solutions for cellular therapy development in autoimmune diseases Elizabeth R Volkmann, John Varga, Bruce R Blazar, Steven Z Pavletic
2024-09-19 [Comment] Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults Alexandra Legge
2024-09-19 [Articles] The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study Sebastian E Sattui, Bohang Jiang, Xiaoqing Fu, Claire Cook, Shruthi Srivatsan, Zachary K Williams, Guy Katz, Yuqing Zhang, Zachary S Wallace
2024-09-19 [Articles] Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study Alexandra Kachaner, Arthur Mageau, Tiphaine Goulenok, Chrystelle François, Nicole Delory, Marie-Paule Chauveheid, Cedric Laouenan, Serge Doan, Caroline Halimi, Isabelle Klein, Thomas Papo, Karim Sacré, French Susac Study Group
2024-09-19 [Comment] Susac syndrome: challenges of interpreting treatment data in a rare disease Todd A Hardy
2024-09-18 [Articles] Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial Quirine A Dumoulin, Doortje I Krijbolder, Karen Visser, Leroy R Lard, Annette H M van der Helm-van Mil
2024-09-18 [Comment] Prevention of seronegative rheumatoid arthritis: an entity of its own Serena Bugatti, Georg Schett
2024-09-11 [Correspondence] Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases Begonya Alcacer-Pitarch, Francesco Del Galdo, Helena Marzo-Ortega
2024-09-03 [Articles] Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial Zhenyu Zhong, Dan Deng, Yu Gao, Qingqing Bu, Lingyu Dai, Xiaojie Feng, Chong Tang, Xiang Luo, Yao Wang, Chunjiang Zhou, Guannan Su, Peizeng Yang
2024-09-03 [Comment] Uveitis relapse in Behçet's disease: a more nuanced approach is needed Jian-long Guan, Jun Zou
2024-08-29 [Articles] The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study Gabrielle Virgili-Gervais, Bianca Matthews, Elsa-Lynn Nassar, Marie-Eve Carrier, Linda Kwakkenbos, John D Pauling, Susan J Bartlett, Amy Gietzen, Karen Gottesman, Geneviève Guillot, Marie Hudson, Laura K Hummers, Amanda Lawrie-Jones, Vanessa L Malcarne, M
2024-08-29 [Comment] Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis Maurizio Cutolo, Vanessa Smith, Elvis Hysa
2024-08-27 [Articles] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials Ioannis Parodis, Julius Lindblom, Roger A Levy, Margherita Zen, Nursen Cetrez, Alvaro Gomez, Shereen Oon, Christine Henning, Munther Khamashta, Holly A Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour
2024-08-27 [Comment] Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab George Bertsias, Jinoos Yazdany
2024-08-23 [Articles] Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study Andreas V Goules, Loukas Chatzis, Vasilis C Pezoulas, Markos Patsouras, Clio Mavragani, Luca Quartuccio, Chiara Baldini, Salvatore De Vita, Dimitrios I Fotiadis, Athanasios G Tzioufas
2024-08-23 [Articles] Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort Karl Gisslander, Arthur White, Louis Aslett, Zdenka Hrušková, Peter Lamprecht, Jacek Musiał, Jamsheela Nazeer, James Ng, Declan O'Sullivan, Xavier Puéchal, Matthew Rutherford, Mårten Segelmark, Benjamin Terrier, Vladimir Tesař, Michelangelo Tesi, Augusto
2024-08-23 [Articles] Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study Juliette Rocca, Maxime Beydon, Véronique Le Guern, Eric Hachulla, Marion Couderc, Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Olivier Vittecoq, Christian Lavigne, Jean Schmidt, Claire Larroche, Xavier Mariette, Raphaèle Se
2024-08-23 [Comment] A future for prediction and treatment of Sjögren's disease-associated lymphomas Suzanne Arends, Arjan Vissink, Frans G M Kroese, Gwenny M Verstappen, Hendrika Bootsma
2024-08-23 [Comment] Reclassifying ANCA-associated vasculitis: a focus on kidney disease Ilay Berke, Andreas Kronbichler
2024-08-15 [Comment] Pregnancy outcome predictors in systemic lupus erythematosus: prospective for brighter perspectives Grégoire Martin de Frémont, Jane E Salmon, Nathalie Costedoat-Chalumeau
2024-08-15 [Articles] Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper, Marieke Sueters, Y K Onno Teng, Isabel J Walter, Judith Kooiman
2024-08-06 [Articles] Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study Melanie Nana, Maria Gregori, Eleanor Chandler, Hazel Powell, Bethan Goulden, Timothy Watts, Mandish K Dhanjal, Catherine Nelson-Piercy
2024-08-06 [Comment] Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism Steven L Clark
2024-08-01 [Comment] Advancing predictive accuracy for shoulder replacement surgery Erica Kholinne, Jae-Man Kwak
2024-08-01 [Articles] Risk of serious adverse events after primary shoulder replacement: development and external validation of a prediction model using linked national data from England and Denmark Epaminondas Markos Valsamis, Marie Louise Jensen, Gillian Coward, Adrian Sayers, Rafael Pinedo-Villanueva, Jeppe V Rasmussen, Gary S Collins, Jonathan L Rees
2024-07-30 [Review] Calcium pyrophosphate deposition disease Tristan Pascart, Georgios Filippou, Frédéric Lioté, Silvia Sirotti, Charlotte Jauffret, Abhishek Abhishek
2024-07-30 [Review] Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis Dylan McGagh, Kaiyang Song, Hang Yuan, Andrew P Creagh, Sally Fenton, Wan-Fai Ng, Jennifer C Goldsack, William G Dixon, Aiden Doherty, Laura C Coates
2024-07-25 [Articles] Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Jonathan S Nguyen Van-Tam, Abhishek Abhishek
2024-07-25 [Comment] Pneumococcal vaccine in adults with immune-mediated inflammatory diseases Meliha C Kapetanovic
2024-07-18 [Viewpoint] Arthritis complicating inflammatory bowel disease— the future is now Kaiyang Song, Jack Satsangi, Laura C Coates
2024-07-17 [Comment] Towards improving the Global Burden of Disease estimates for low back pain Mark Hancock, Alice Kongsted
2024-07-17 [Articles] Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework YiFan Wu, Sarah Wulf Hanson, Garland Culbreth, Caroline Purcell, Peter Brooks, Jacek Kopec, Lyn March, Anthony D Woolf, Maja Pasovic, Erin Hamilton, Damian Santomauro, Theo Vos
2024-07-17 [Insights] Fighting to be heard—a painful journey of misdiagnoses Luc J Beck, Katherine I Wolf
2024-07-10 [Comment] Gout prevalence is rising in low-income and middle-income countries: are we ready? Kanon Jatuworapruk
2024-07-10 [Articles] Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 GBD 2021 Gout Collaborators
2024-07-04 [Review] Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care Laura E Eades, Alberta Y Hoi, Ruaidhri Liddle, Jason Sines, Rangi Kandane-Rathnayake, Sachin Khetan, Johannes Nossent, Greta Lindenmayer, Eric F Morand, David F L Liew, Maureen Rischmueller, Stephen Brady, Alex Brown, Fabien B Vincent
2024-07-04 [Clinical Picture] Painful scalp nodules in SAPHO syndrome Clément Triaille, Victor Kokta, Julie Powell, Jean Jacques De Bruycker
2024-07-03 [Corrections] Correction to Lancet Rheumatol 2023; 5: e130–38
2024-06-28 [Articles] Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study Titilola Falasinnu, Di Lu, Matthew C Baker
2024-06-28 [Comment] Trends in opioid use for autoimmune rheumatic diseases Erika P Navarro-Mendoza, Alí Duarte-García
2024-06-27 [Comment] Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study Elsa-Lynn Nassar, Gabrielle Virgili-Gervais, Marie-Eve Carrier, Linda Kwakkenbos, Richard S Henry, Sophie Hu, Sabrina Provencher, Meira Golberg, Susan J Bartlett, Luc Mouthon, Scott B Patten, John Varga, Andrea Benedetti, Brett D Thombs, Scleroderma Patie
2024-06-26 [Articles] Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial Claudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, Benjamin A Fisher, Antoni Chan, Raj Sengupta, Jonathan Packham, Karl Gaffney, Nicola Gullick, Jonathan A Cook, Tim H Corn, James Teh, Pedro M Machado, Peter C Taylor, Paul Bowness
2024-06-26 [Comment] Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts Walter P Maksymowych
2024-06-20 [Clinical Picture] Pachydermodactyly: mimic of arthritis in a young man Cassandra Michelle Skinner-Taylor, Pablo Gamez-Siller, Brenda Cantu-Garza, Hector Guerra, Héctor Teodoro Rios-Bazaldua, Dionicio Angel Galarza-Delgado, Jesus Alberto Cardenas-de la Garza
2024-06-19 [Comment] Engagement of people with lived experience in studies published in high-impact rheumatology journals: a meta-research review Claire Adams, Elsa-Lynn Nassar, Julia Nordlund, Cassidy Dal Santo, Danielle B Rice, Vanessa Cook, Jill T Boruff, Brett D Thombs
2024-06-18 [Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty Fu-Shan Xue, Dao-Yi Lin, Xiao-Chun Zheng
2024-06-18 [Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty – Authors' reply Joakim Steiness, Troels Haxholdt Lunn, Daniel Hägi-Pedersen, Janus Christian Jakobsen, Ole Mathiesen
2024-06-15 [Clinical Picture] Takayasu arteritis-associated periostitis in the distal femur mimicking periosteal osteosarcoma Mariko M Kawamura, Robert Nakayama, Sayaka I Yamaguchi, Satoshi Kamio, Toru Hirozane, Tomoaki Mori, Naofumi Asano, Hajime Okita, Morio Matsumoto, Masaya Nakamura
2024-06-13 [Articles] Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries Eleana Bolla, Anne Grete Semb, Anne M Kerola, Eirik Ikdahl, Michelle Petri, Guillermo J Pons-Estel, George A Karpouzas, Petros P Sfikakis, Rosana Quintana, Durga Prasanna Misra, Eduardo Ferreira Borba, Ignacio Garcia-de la Torre, Tatiana V Popkova, Bahar
2024-06-13 [Comment] Systemic lupus erythematosus: managing cardiovascular risk factors Anisur Rahman
2024-06-12 [Articles] Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study Vera Golder, Rangi Kandane-Rathnayake, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Wu, Sandra V Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi H
2024-06-12 [Comment] Research, pregnancy, and the ethics of parental consent Anne Drapkin Lyerly
2024-06-12 [Insights] Silvia Aguilera: learning from lived experience Udani Samarasekera
2024-06-12 [Series] The outcomes of children born to mothers with autoimmune rheumatic diseases Laura Andreoli, Jeanette Andersen, Tadej Avcin, Christina D Chambers, Elisa M Fazzi, Neil Marlow, Nico M Wulffraat, Angela Tincani
2024-06-12 [Series] The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management Ian Giles, Iona Thorne, Nanna Surlemont Schmidt, Claire Reid, Amy Crossley, Monica Panca, Nick Freemantle, Clare Tower, Shouvik Dass, Shefali K Sharma, David Williams, Sean O'Neill, Radboud J E M Dolhain, Nataša Toplak, Kenneth Hodson, Catherine Nelson-Pi
2024-06-12 [Series] Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people Karen Schreiber, Christine Graversgaard, Beverley J Hunt, James M S Wason, Nathalie Costedoat-Chalumeau, Silvia Aguilera, Marta M Guerra, Jane E Salmon
2024-06-12 [Comment] For SLE activity and glucocorticoids: aim low Martin Aringer, Jinoos Yazdany
2024-06-04 [Articles] Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Sharon Douglas, Helen E Foster, Taunton R Southwood, Kimme L Hyrich, UK JIA Biologics Register
2024-06-04 [Comment] Biosimilars in childhood chronic rheumatic diseases: friend or foe? Ilaria Maccora, Gabriele Simonini
2024-05-31 [Articles] Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria Isha Jha, Grace A McMahon, Cory A Perugino, Guy Katz, Zachary S Wallace, Ana Fernandes, Bohang Jiang, Yuqing Zhang, Aubree E McMahon, Thomas V Guy, Hang Liu, Yasmin G Hernandez-Barco, Shiv Pillai, John H Stone
2024-05-31 [Articles] Supporting self-management of low back pain with an internet intervention with and without telephone support in primary care (SupportBack 2): a randomised controlled trial of clinical and cost-effectiveness Adam W A Geraghty, Taeko Becque, Lisa C Roberts, Jonathan C Hill, Nadine E Foster, Lucy Yardley, Beth Stuart, David A Turner, Elaine Hay, Gareth Griffiths, Frances Webley, Lorraine Durcan, Alannah Morgan, Stephanie Hughes, Sarah Bathers, Stephanie Butler-
2024-05-31 [Comment] Welcome new evidence on self-management of back pain Chris Maher, Chung-Wei Christine Lin
2024-05-31 [Comment] Sex bias in IgG4-related disease: from clinical phenotype to mechanisms Jiaxin Zhou, Wen Zhang
2024-05-22 [Insights] Stop ticking boxes: it just doesn't work Jules Morgan

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选